Truvestments Capital LLC Abb Vie Inc. Transaction History

Truvestments Capital LLC

$245 Million
Q2 2024

A detailed history of Truvestments Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 19,739 shares of ABBV stock, worth $3.84 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares

19,739

Previous 19,525 1.1%

Holding current value

$3.84 Million

Previous $3.56 Million 4.78%

% of portfolio

1.38%

Previous 1.41%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $33,125 - $38,682	214 Added 1.1%	19,739 $3.39 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $1.01 Million - $1.15 Million	6,317 Added 47.83%	19,525 $3.56 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $203,785 - $229,510	1,481 Added 12.63%	13,208 $2.05 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $65,459 - $75,778	490 Added 4.36%	11,727 $1.75 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $122,969 - $153,027	928 Added 9.0%	11,237 $1.51 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $186,836 - $215,169	-1,292 Reduced 11.14%	10,309 $1.64 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $1.61 Million - $1.93 Million	-11,620 Reduced 50.04%	11,601 $1.88 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $139,712 - $160,241	1,041 Added 4.69%	23,221 $3.12 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $26,973 - $34,292	196 Added 0.89%	22,180 $3.4 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $1,055 - $1,310	-8 Reduced 0.04%	21,984 $3.56 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $53,177 - $67,285	495 Added 2.3%	21,992 $2.98 Million
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $91,184 - $103,508	857 Added 4.15%	21,497 $2.32 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $128,040 - $142,644	1,217 Added 6.27%	20,640 $2.33 Million
Q1 2021 May 18, 2021	BUY	$102.3 - $112.62 $216,569 - $238,416	2,117 Added 12.23%	19,423 $2.1 Million
Q4 2020 Feb 17, 2021	BUY	$80.49 - $108.67 $56,182 - $75,851	698 Added 4.2%	17,306 $1.85 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $234,534 - $275,265	-2,730 Reduced 14.12%	16,608 $1.45 Million
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $138,742 - $185,658	-1,891 Reduced 8.91%	19,338 $1.9 Million
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $32,959 - $49,970	511 Added 2.47%	21,229 $1.62 Million
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $83,093 - $103,968	1,152 Added 5.89%	20,718 $1.83 Million
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $297,454 - $357,625	4,723 Added 31.82%	19,566 $1.48 Million
Q2 2019 Jul 15, 2019	BUY	$65.7 - $83.98 $498,991 - $637,828	7,595 Added 104.79%	14,843 $1.08 Million
Q1 2019 Apr 12, 2019	SELL	$77.14 - $90.79 $560,344 - $659,498	-7,264 Reduced 50.06%	7,248 $584,000
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $41,165 - $45,762	463 Added 3.3%	14,512 $1.37 Million
Q2 2018 Aug 28, 2018	BUY	$89.78 - $106.23 $1.26 Million - $1.49 Million	14,049 New	14,049 $1.3 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.

Account

Truvestments Capital LLC Abb Vie Inc. Transaction History